Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-11,201
Closed -$332K 32
2014
Q4
$332K Buy
11,201
+1,210
+12% +$34.7K 0.48% 28
2014
Q3
$280K Buy
9,991
+6,060
+154% +$170K 0.24% 41
2014
Q2
$111K Buy
3,931
+1,370
+53% +$39.1K 0.08% 54
2014
Q1
$78K Sell
2,561
-10,688
-81% -$319K 0.07% 66
2013
Q4
$385K Buy
13,249
+359
+3% +$10.4K 0.36% 34
2013
Q3
$375K Sell
12,890
-63,240
-83% -$1.72M 0.36% 34
2013
Q2
$2.02M Buy
+76,130
New +$2.1M 1.88% 23

Other funds holding PFE

CFS LLC's PFE Position: Q1 2015 in Review

CFS LLC sold out of Pfizer (PFE) in Q1 2015, closing a stake of 11,201 shares — an estimated $332K sold.

CFS LLC first reported a position in PFE in Q2 2013 and held it in 7 quarters. The position peaked at $2.02M in Q2 2013. 1,875 funds tracked by Wall St. Rank hold PFE as of Q1 2015.

  • CFS LLC reported no remaining Pfizer position as of Q1 2015 after selling out during the quarter.
  • CFS LLC sold 11,201 Pfizer shares in Q1 2015, an estimated $332K.
  • CFS LLC first reported a position in Pfizer in Q2 2013 and held it in 7 quarters.
  • CFS LLC's Pfizer position peaked at $2.02M in Q2 2013.
  • 1,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2015.

Based on CFS LLC's 13F filing for Q1 2015, filed 15 May 2015.